State of the Landscape: Medtech, Diagnostics & Digital Health in Q3 2026

In this update, we explore the investment landscape across medtech, diagnostics, and digital health in Q3 2026.  

The quarter saw 127 deals, down for the second quarter in a row (163 in Q1, 140 in Q2). Total reported value was $8.4B, a large part of which came from Bayer-related deals and Neko Health’s Series C. Venture rounds were the largest group, with 61 rounds raising $1.5B.

We also put the spotlight on two companies that raised funding, both of which are indicative of market trends.